Sign up
Pharma Capital

Launch of CellPlan set to generate maiden revenues - WideCells CEO Joao Andrade

WideCells Group PLC (LON:WDC)  chief executive Joao Andrade and non-executive director Dr Marilyn Orcharton tell Proactive's Andrew Scott they're now fully authorised to sell CellPlan in the UK, Portugal and Spain.

 

 

View full WDC profile

WideCells Group Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.